TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
1.040
-0.040 (-3.70%)
May 12, 2025, 11:20 AM - Market open
TELA Bio Stock Forecast
TELA's stock price has decreased by -77.5% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for TELA Bio stock ranges from a low of $2.00 to a high of $8.00. The average price target of $6.00 forecasts a 476.92% increase in the stock price over the next year.
Price Target: $6.00 (+476.92%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 21, 2025.
Analyst Ratings
The average analyst rating for TELA Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 → $7 | Strong Buy | Maintains | $12 → $7 | +573.08% | Mar 21, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Maintains $12 → $7 | Buy | Maintains | $12 → $7 | +573.08% | Mar 21, 2025 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $5 → $2 | Buy → Hold | Downgrades | $5 → $2 | +92.31% | Mar 21, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $8 → $5 | Buy | Maintains | $8 → $5 | +380.77% | Nov 8, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +1,053.85% | Oct 4, 2024 |
Financial Forecast
Revenue This Year
87.25M
from 69.30M
Increased by 25.90%
Revenue Next Year
107.31M
from 87.25M
Increased by 23.00%
EPS This Year
-0.67
from -1.33
EPS Next Year
-0.37
from -0.67
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 90.6M | 114.5M | 141.8M | |
| Avg | 87.2M | 107.3M | 130.1M | |
| Low | 83.1M | 99.6M | 117.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 30.8% | 31.3% | 32.1% | |
| Avg | 25.9% | 23.0% | 21.2% | |
| Low | 19.9% | 14.1% | 9.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -0.48 | -0.11 | 0.22 | |
| Avg | -0.67 | -0.37 | 0.11 | |
| Low | -0.84 | -0.64 | 0.01 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.